US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...

Artificial intelligence (AI) is reshaping the pharmaceutical industry ... a Swiss biotechnology company spun out of ETH Zurich, and co-founded Nymirum, a private venture backed biotechnology ...

ETH Zurich supports interdisciplinary collaborations of researchers both within institutional networks, as well as with other scientific partners and industry. The aim is always to expand the ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...

The automation company Festo and ETH Zurich are creating soft robotic actuators with muscle ... through collaboration and exchange with industry, policymakers, public administration, and society at ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions drag on. By Jeanna Smialek Liz Alderman and Melissa Eddy Jeanna Smialek ...

about the impact geopolitical changes in Europe might have on the bio/pharmaceutical industry. Political shifts in the United Kingdom and Europe may have a negative impact on research efforts for gene ...

about how the political landscape may impact the pharmaceutical industry. The fundamentals of healthcare are established and supported in the United States, Alexander Seyf, CEO and co-founder of ...

Kennedy Jr. has vilified the drug industry’s profits and questioned the safety of its products. Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for ...

The pharma industry has waged a massive lobbying campaign over recent years, to water down key aspects of the planned overhaul. Other countries with big pharma sectors, such as Germany ...